Loading…
This event has ended. Visit the official site or create your own event on Sched.
Meet experts and network with your peers at Techstars Startup Week Seattle!

View analytic
Tuesday, October 3 • 3:00pm - 5:00pm
Science NOT Science Fiction: Medical Technologies of the Near Future

Log in to save this to your schedule and see who's attending!

Tumor zapping, genomics, predictive and proactive medicine: Seattle is home base for some mind-boggling developing technologies and you have a front row seat! Come to be inspired by the leaders who are pioneering the personalized and targeted approaches to medicine that will change the way we manage our health.

Things to know: We’ll serve snacks, take your questions and provide time before and after the event for networking.

*This event will be seated on a first come, first served basis. You must be registered to attend however it does not guarantee entry. 

Moderators
avatar for Terri Butler

Terri Butler

Assistant Director, U Washington
Terri runs the UW Hollomon Health Innovation Challenge, a student entrepreneurship competition, and advises startup companies during their launch phase. She has been co-founder and early on-board at a number of startups in the chemical and biotechnology industries. She consulted on technology commercialization at Berkeley Labs, served as an Entrepreneur-in-Residence at the University of Washington, and her industry experience includes market development and regulatory affairs in a pharmaceutical/nutritional products startup, sales in an early-stage monoclonal antibody company, and product development at 3M Company. Terri holds a... Read More →

Speakers
avatar for Sean Bell

Sean Bell

Chief Business Officer, Arivale, Inc.
Sean is Chief Business Officer at Arivale. He has spent the past twelve years working in companies that help people achieve better health. Prior to joining Arivale, Sean was the Executive Vice President at Free & Clear, the nation’s leading health coaching company for tobacco cessation and healthy nutrition and activity, where he helped build a business that assisted over 400,000 people per year in living healthier, more productive lives. He was responsible for marketing, product management, information technology, software development, clinical affairs, research, evaluation and training services... Read More →
avatar for Alex Jiao

Alex Jiao

President and CEO, Silene Biotech
Silene Biotech wants to help you to grow a new heart or liver – in case those organs fail later in life and offers consumers a way to store their cells, and retrieve them to use later for regenerative medicine applications and personalized medicine. The company focuses on induced pluripotent stem cell (iPS) technology. These cells are engineered in the lab from an... Read More →
avatar for Kaveri Parker

Kaveri Parker

President and CEO, ID Genomics
Kaveri Parker is a Principal Investigator on a $3,000,000 STTR Phase II grant from NIH/NIAID, and has successfully led the Company’s first financing round. She has also added 9 clinical partners to BactNet’s nationwide clinical consortium, including the Group Health Research Institute. Kaveri has an active role in ID... Read More →
avatar for Rhonda Rhyne

Rhonda Rhyne

CEO and President, Prevencio, Inc.
Ms. Rhonda F. Rhyne, M.B.A has been the Chief Executive Officer and President of Prevencio, Inc. since October 2013. Ms. Rhyne is a Principal of Rhyne Life Sciences Consulting. She has more than 25 years of experience in health care with both public and private industry companies, as well as experience as a clinical pharmacist. Ms. Rhyne is a medical technology industry leader. She served as the President of CardioDynamics International Corporation since June 1997. Prior to CardioDynamics, she served as Chief Executive Officer, President and Vice President of Sales... Read More →
avatar for Chris Rivera

Chris Rivera

President, CEO and Chairman of the Board, Nativis, Inc.
Chris Rivera has more than 30 years of experience in the biotechnology industry. He was the Founder and CEO of Hyperion Therapeutics, which was acquired by Horizon Pharma in 2015, the Senior Vice President and head of Commercial Operations at both Tercica and Genzyme Therapeutics, where he built and ran... Read More →


Tuesday October 3, 2017 3:00pm - 5:00pm
Cambia Grove 1800 9th Avenue, Suite 200, Seattle, WA 98101

Attendees (182)